Savara
SVRA
#6233
Rank
โ‚น103.07 B
Marketcap
โ‚น501.70
Share price
-4.19%
Change (1 day)
74.10%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -โ‚น11.62 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น11.34 Billion a decrease over its 2024 earnings that were of -โ‚น9.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น11.62 Billion2.44%
2025 -โ‚น11.34 Billion23.94%
2024 -โ‚น9.15 Billion75.29%
2023 -โ‚น5.22 Billion43.38%
2022 -โ‚น3.64 Billion-11.31%
2021 -โ‚น4.11 Billion-13.3%
2020 -โ‚น4.74 Billion-36.53%
2019 -โ‚น7.46 Billion13.76%
2018 -โ‚น6.56 Billion105.54%
2017 -โ‚น3.19 Billion34.11%
2016 -โ‚น2.38 Billion-37.43%
2015 -โ‚น3.81 Billion38.81%
2014 -โ‚น2.74 Billion33.62%
2013 -โ‚น2.05 Billion38.49%
2012 -โ‚น1.48 Billion24.59%
2011 -โ‚น1.19 Billion-36.5%
2010 -โ‚น1.87 Billion-3.14%
2009 -โ‚น1.94 Billion-23.28%
2008 -โ‚น2.52 Billion8.52%
2007 -โ‚น2.32 Billion-34.14%
2006 -โ‚น3.53 Billion184.43%
2005 -โ‚น1.24 Billion90.75%
2004 -โ‚น0.65 Billion190.35%
2003 -โ‚น0.23 Billion11.64%
2002 -โ‚น0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น21.84 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.74 Billion-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA